Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies - Episode 5

Updated Analysis of the POSEIDON Trial in mNSCLC from World Lung 2022

Dr Garon continues with an explanation of the updated analysis of the POSEIDON trial presented at the 2022 World Conference on Lung Cancer.